TY - JOUR
T1 - Mitochondrial gateways to cancer
AU - Galluzzi, Lorenzo
AU - Morselli, Eugenia
AU - Kepp, Oliver
AU - Vitale, Ilio
AU - Rigoni, Alice
AU - Vacchelli, Erika
AU - Michaud, Mickael
AU - Zischka, Hans
AU - Castedo, Maria
AU - Kroemer, Guido
N1 - Funding Information:
The authors declare no conflicting financial interests. This work was supported by grants from Ligue Nationale contre le Cancer (LNC), Agence Nationale de Recherche (ANR), Agence Nationale de Recherches sur le SIDA (ANRS), Institut National du Cancer (INCa), Cancéropôle Ile-de-France, Fondation pour la Recherche Médicale (FRM), Sidaction and the European Commission (Active p53, Apo-Sys, ApopTrain, TransDeath, RIGHT). O.K. is the recipient of an EMBO Ph.D. fellowship. E.M. is funded by an ApopTrain Ph.D. student fellowship.
PY - 2010/2/1
Y1 - 2010/2/1
N2 - Mitochondria are required for cellular survival, yet can also orchestrate cell death. The peculiar biochemical properties of these organelles, which are intimately linked to their compartmentalized ultrastructure, provide an optimal microenvironment for multiple biosynthetic and bioenergetic pathways. Most intracellular ATP is generated by mitochondrial respiration, which also represents the most relevant source of intracellular reactive oxygen species. Mitochondria participate in a plethora of anabolic pathways, including cholesterol, cardiolipin, heme and nucleotide biosynthesis. Moreover, mitochondria integrate numerous pro-survival and pro-death signals, thereby exerting a decisive control over several biochemical cascades leading to cell death, in particular the intrinsic pathway of apoptosis. Therefore, it is not surprising that cancer cells often manifest the deregulation of one or several mitochondrial functions. The six classical hallmarks of cancer (i.e., limitless replication, self-provision of proliferative stimuli, insensitivity to antiproliferative signals, disabled apoptosis, sustained angiogenesis, invasiveness/metastatic potential), as well as other common features of tumors (i.e., avoidance of the immune response, enhanced anabolic metabolism, disabled autophagy) may directly or indirectly implicate deregulated mitochondria. In this review, we discuss several mechanisms by which mitochondria can contribute to malignant transformation and tumor progression.
AB - Mitochondria are required for cellular survival, yet can also orchestrate cell death. The peculiar biochemical properties of these organelles, which are intimately linked to their compartmentalized ultrastructure, provide an optimal microenvironment for multiple biosynthetic and bioenergetic pathways. Most intracellular ATP is generated by mitochondrial respiration, which also represents the most relevant source of intracellular reactive oxygen species. Mitochondria participate in a plethora of anabolic pathways, including cholesterol, cardiolipin, heme and nucleotide biosynthesis. Moreover, mitochondria integrate numerous pro-survival and pro-death signals, thereby exerting a decisive control over several biochemical cascades leading to cell death, in particular the intrinsic pathway of apoptosis. Therefore, it is not surprising that cancer cells often manifest the deregulation of one or several mitochondrial functions. The six classical hallmarks of cancer (i.e., limitless replication, self-provision of proliferative stimuli, insensitivity to antiproliferative signals, disabled apoptosis, sustained angiogenesis, invasiveness/metastatic potential), as well as other common features of tumors (i.e., avoidance of the immune response, enhanced anabolic metabolism, disabled autophagy) may directly or indirectly implicate deregulated mitochondria. In this review, we discuss several mechanisms by which mitochondria can contribute to malignant transformation and tumor progression.
KW - Bcl-2
KW - Caspases
KW - Mitochondrial transmembrane potential
KW - Oncoproteins
KW - Tumor suppressors
KW - p53
UR - http://www.scopus.com/inward/record.url?scp=77649338652&partnerID=8YFLogxK
U2 - 10.1016/j.mam.2009.08.002
DO - 10.1016/j.mam.2009.08.002
M3 - Review article
C2 - 19698742
AN - SCOPUS:77649338652
SN - 0098-2997
VL - 31
SP - 1
EP - 20
JO - Molecular Aspects of Medicine
JF - Molecular Aspects of Medicine
IS - 1
ER -